2022
DOI: 10.1590/1516-3180.2021.0842.r1.13102021 View full text |Buy / Rent full text
|
|

Abstract: BACKGROUND: Lung transplantation (LTx) has been discussed as an option for treating irreversible lung fibrosis post-coronavirus disease 2019 (COVID-19), in selected cases. OBJECTIVES: To report on the initial experience and management of end-stage lung disease due to COVID-19 at a national center reference in Brazil. DESIGN AND SETTING: Cohort study conducted at a national reference center for lung transplantation. METHODS: Medical charts were reviewed regarding patients' demographics and pre-COVID-19 characte… Show more

Help me understand this report

Search citation statements

Order By: Relevance
0
0
0
0
0
0
0
0

Publication Types

Select...

Relationship

0
0

Authors

Journals